Status of research on gender differences

Journal of the American Pharmaceutical Association

Volumn 37, Issue 1, 1997, Pages 43-56

  Berg, M J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CARBAMAZEPINE; PHENAZONE; PHENOBARBITAL; PHENYTOIN; TERFENADINE; THEOPHYLLINE; XYLOSE; ZIDOVUDINE;

CLINICAL TRIAL; DRUG MILK LEVEL; DRUG RESEARCH; DRUG USE; FEMALE; GENDER; HUMAN; MALE; NUTRITION; PHARMACEUTICAL CARE; PHARMACODYNAMICS; PHARMACOKINETICS; PREGNANCY; REVIEW; ADOLESCENT; ADULT; METHODOLOGY; MIDDLE AGED; SEX DIFFERENCE; UNITED STATES; WOMEN'S HEALTH;

ADOLESCENT; ADULT; CLINICAL TRIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACOKINETICS; PREGNANCY; RESEARCH DESIGN; SEX FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 0031053568     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1086-5802(16)30190-5     Document Type: Article

References (52)

1. G. Levy Patient-oriented pharmaceutical research: focus on the individual Pharmaceutical Res. 12 1995 943 944
2. E.M. Rathegeber C. Vlassoff Gender and tropical diseases: a new approach SocSci Med. 37 1993 513 520
3. Women's Health—Towards a Better World. Geneva, Switzerland: World Health Organization 1994 WHO publication 94.4
4. D.L. Schmucker E.S. Vessell Underrepresentation of women in clinical drug trials Clin Pharmacol Ther. 54 1993 11 15
5. E.L. Kinney J. Trautman J.A. Gold Underrepresentation of women in new drug trials: ramifications and remedies Ann Intern Med. 95 1981 495 499
6. B.A. Levey Bridging the gender gap in research Clin Pharmacol Ther. 50 1991 641 646
7. K.G. Low M.R. Joliceour R.A. Colman Women participants in research: assessing progress Women's Health. 22 1995 79 98
8. J.H. La Rosa V.W. Pinn Gender Bias in biomedical research J Am Med Women's Assoc. 43 1993 145 151
9. J.K. Bush The industry perspective on the inclusion of women in clinical trials Academ Med. 69 1994 708 715
10. L.A. Wanke M.L. Kleinberg New approaches and technologies in drug design and discovery Am J Health-Syst Pharm. 52 1995 1323 1326
11. V.K. Nayak A. Kshirsagar N.K. Desai R.S. Satoskar Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers Brit J Clin Pharmacol. 26 1988 604 606
12. J.A. Cordaro G.D. Morse L. Bartos Zidovudine pharmacokinetics in the HIV-positive during different phases of the menstrual cycle Pharmacotherapy. 13 1993 369 377
13. L.E. Gustavson U.F. Legler L.Z. Benet Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens J Clin Endocrinol Metab. 62 1986 234 237
14. R.K. Roberts P.V. Desmond G.R. Wilkinson Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives Clin Pharmacol Ther. 25 1979 826 831
15. H.R. Ochs D.J. Greenblatt H. Friedman Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol Clin Pharmacol Ther. 41 1987 562 570
16. M.S. Yerby P.N. Fried K.L. McCormick Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding Epilepsy Res. 5 1990 223 228
17. Berg MJ, Chenard C, Stumbo P, et al. Folic Acid ( FA ), Zinc ( ZN ) and Vitamin B - 12 : Pregnancy ( PREG ) and Postpartum ( PP ). Washington, D.C.: Federation of American Societies for Experimental Biology; Abstract # 2978; 1996.
18. D.P. Lewis P.S. Stumbo D. Van Dyke Phenytoin/folic acid review: an update Ann Pharmacother. 29 1995 726 735
19. M.J. Berg R.W. Fincham B.E. Ebert Decrease of serum folates in healthy male volunteers taking phenytoin Epilepsia. 26 1988 67 73
20. M.J. Berg P.J. Stumbo C.A. Chenard Folic acid improves phenytoin pharmacokinetics J Am Diet Assoc. 95 1995 352 356
21. M.P. Rivey D.D. Schottelius M.J. Berg Phenytoin-folic acid: a review Drug Intel Clin Pharm. 18 1984 292 301
22. D. Van Dyke M.J. Berg C. Olson A review of differences in phenytoin biotransformation and susceptibility to congenital malformation Ann Pharmacother. 25 1991 929 932
23. M.J. Berg R.W. Fincham B.E. Ebert Phenytoin pharmacokinetics before and after folic acid administration Epilepsia. 33 1992 712 720
24. S. Stavchansky A. Combs R. Sagraves Pharmacokinetics of caffeine in breast milk and plasma after single oral administration of caffeine to lactating mothers Biopharm Drug Disp. 9 1988 285 299
25. B.D. Lucas C.Y. Purdy S.K. Scarim Terfenadine pharmacokinetics in breast milk in lactating women Clin Pharmacol Ther. 57 1995 398 402
26. J. Vanakoski C. Stromberg T. Seppala Effects of a sauna on the pharmacokinetics and pharmacodynamics of midazolom and ephedrine in healthy young women Eur J Clin Pharmacol. 45 1993 377 381
27. T. Walle R.P. Byington C.D. Furberg Biologic determinants of propranolol disposition: results from 1308 patients in the beta-blocker heart attack trial Clin Pharmacol Ther. 38 1985 509 518
28. T. Walle U.K. Walle T.D. Cowart Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects Clin Pharmacol Ther. 46 1989 257 263
29. J.B. Schwartz H. Capili J. Daugherty Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics Clin Pharmacol Ther. 55 1994 509 517
30. C.M. Hunt W.R. Westerkam G.M. Stave Effect of age and gender on the activity of human hepatic CYP3A Biochem Pharmacol. 44 1992 275 283
31. M.V. Relling J.S. Lin G.D. Ayers Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities Clin Pharmacol Ther. 52 1992 643 658
32. K.H. Lew E.A. Ludwig M.A. Milad Gender-based effects on methyl prednisolone pharmacokinetics and pharmacodynamics Clin Pharmacol Ther. 54 1993 402 414
33. W.W. Pinn The role of the NIH Office of Research on Women's Health Acad Med. 9 1994 698 702
34. B.B. Biesecker M. Boehnke K. Calzone Genetic counseling for families with inherited susceptibility to breast and ovarian cancer JAMA. 269 1993 1970 1974
35. Report of the National Institutes of Health: Opportunities for Research on Women's Health 1992 U.S. Department of Health and Human Services. Public Health Service publication NIH 92-3457 Hunt Valley, Md
36. R.B. Merkatz S.W. Junod Historical background of changes in FDA policy on the study and evaluation of drugs in women Academ Med. 69 1994 703 707
37. K.G. Low M.R. Joliceour R.A. Colman Women participants in research: assessing progress Women's Health. 22 1995 79 98
38. D.L. Schmucker E.S. Vessell Underrepresentation of women in clinical drug trials Clin Pharmacol Ther. 54 1993 11 15
39. S. Stavchansky A. Combs R. Sagraves Pharmacokinetics of caffeine in breast milk and plasma after single oral administration of caffeine to lactating mothers Biopharm Drug Disp. 9 1988 285 299
40. B.D. Lucas C.Y. Purdy S.K. Scarim Terfenadine pharmacokinetics in breast milk in lactating women Clin Pharmacol Ther. 57 1995 398 402
41. J.I.T. Isojärvi T.J. Laatikainen A.J. Pakarinen Menstrual disorders in W women with epilepsy receiving carbamazepine Epilepsia. 36 1995 676 681
42. C. Fiset M. LeBel Influence of the menstrual cycle on the absorption and elimination of D-xylose Clin Pharmacol Ther. 48 1990 529 536
43. B. Bruguerolle M. Toomim F. Faraj Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics Eur J Clin Pharmacol. 39 1990 59 61
44. J.A. Cordaro G.D. Morse L. Bartos Zidovudine Pharmacokinetics in the HIV-positive women during different phases of the menstrual cycle Pharmacotherapy. 13 1993 369 377
45. V.K. Nayak A. Kshirsagar N.K. Desai R.S. Satoskar Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers Brit J Clin Pharmacol. 26 1988 604 606
46. M.S. Yerby P.N. Fried K.L. McCormick Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding Epilepsy Res. 5 1990 223 228
47. S.L. Miaskewicz C.A. Shivelly E.S. Vessell Sex differences in absorption kinetics of sodium salicylate Clin Pharmacol Ther. 31 1982 30 37
48. G. Shavit P. Lerman A. Korcsyn Phenytoin pharmacokinetics in catamenial epilepsy Neurology. 34 1984 959 961
49. J. Wojcicki B. Gawronska-Szklarz J. Kazimierczk Comparative pharmacokinetics of paracetamol in men and women conducting follicular and luteal phases Arzneimittelforschung 29 1979 350 352
50. P. Backstrom P. Jorpes Serum phenytoin, phenobarbital, carba mazepine, albumin and plasma estradiol-progesterone concentrations during the menstrual cycle in women with epilepsy Acta Neurol Scand. 58 1979 63 71
51. R. Jochemsen M. Vander Graaf J.K. Boeijinga Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam Br J Clin Pharmacol. 13 1982 319 324
52. B.M. Jones M.K. Jones Alcohol effects in women during the menstrual cycle Ann NY Acad Sci. 273 1976 576 587